Incannex website
Web1 day ago · Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has secured the aid of Quest Pharmaceutical Services to provide regulatory advice and manage clinical trials for the development of CannQuit™ and ReneCann™ products for addiction and immune-disordered skin diseases in the US and EU. IHL is targeting nicotine and opioid addiction with its … WebJul 21, 2024 · Incannex is listed on the Australian Stock Exchange (ASX) with stock code "IHL" and also has American Depository Shares listed on NASDAQ under code "IXHL". Website: www.incannex.com.au...
Incannex website
Did you know?
WebIncannex Healthcare Limited 1,254 followers on LinkedIn. Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of anxiety disorders, obstructive sleep apnoea (OSA), traumatic brain injury (TBI)/concussion, lung … WebAug 17, 2024 · Incannex Healthcare Limited. Mr Joel Latham. Managing Director and Chief Executive Officer. +61 409 840 786. [email protected]. Investor Relations Contact – United States. Alyssa Factor ...
WebIncannex Healthcare Limited 1,254 followers on LinkedIn. Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis … Web1 day ago · Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has secured the aid of Quest Pharmaceutical Services to provide regulatory advice and manage clinical trials for the …
WebMay 12, 2024 · Incannex is listed on the Australian Stock Exchange (ASX) with stock code "IHL" and also has American Depository Shares listed on NASDAQ under code "IXHL". Website: www.incannex.com.au... Web1 day ago · Website: www.incannex.com.au Investors: [email protected]. Forward-looking statements This press release contains "forward-looking statements" …
WebApr 14, 2024 · Incannex (IHL) has appointed Quest Pharmaceutical Services (QPS) to provide regulatory advice and manage the company’s clinical trials for its CannQuit and …
Web1 day ago · Melbourne, Australia, April 14, 2024 - Incannex Healthcare Ltd (Nasdaq: IXHL). (ASX: IHL) ('Incannex' or 'the Company') a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs is pleased to announce that is has appointed Quest Pharmaceutical … geography what is troyWebApr 14, 2024 · Website: www.incannex.com.au Investors: [email protected]. Forward-looking statements This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date they were first … chris seusing wood smithWebIncannex Healthcare Ltd (IHL) Stock Price & News - Google Finance Home IHL • ASX Incannex Healthcare Ltd Follow Share $0.14 Apr 4, 5:22:01 AM GMT+10 · AUD · ASX · Disclaimer search Compare to... chris seuferling podiatristWebApr 14, 2024 · Website: www.incannex.com.au Investors: [email protected]. Forward-looking statements This press release contains "forward-looking statements" within the meaning of the "safe harbor ... chris severn philadelphia fedWebMar 9, 2024 · Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has wrapped up preliminary analysis of data from its Phase 2 proof-of-concept clinical trial investigating novel cannabinoid combination drug candidate IHL-42X for the treatment of obstructive sleep apnoea (OSA). The clinical trial assessed the efficacy of three doses of IHL-42X – … geography y1WebApr 14, 2024 · Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic … chris severnsWebFind the latest Incannex Healthcare Limited (IHL.AX) stock quote, history, news and other vital information to help you with your stock trading and investing. chris seufert attorney